Clinical Decision Tree Analysis of Hemodialysis Arteriovenous Access Choices and Creations - a Multiple-center Retrospective Cohort Study
1 other identifier
observational
600
1 country
1
Brief Summary
Our study aim was to utilize a decision tree analysis (DTA) model to gain insight into the decision-making process within a multiple-center cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 13, 2023
CompletedFirst Submitted
Initial submission to the registry
April 9, 2024
CompletedFirst Posted
Study publicly available on registry
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedJune 19, 2025
May 1, 2025
7 months
April 9, 2024
June 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
predicted AV access choices
identifying parameters that predicted AV access choices among the four types
postoperativ 3 -12 months
Secondary Outcomes (1)
to determine factors affecting clinical use of the targeted AV access over a variable timeframe
postoperativ 3 -12 months
Study Arms (4)
AVF-wrist
AVF-elbow
AVG-forearm
AVG-elbow
Interventions
Eligibility Criteria
chronic kidney disease (CKD) and were in the pre-kidney replacement therapy (pre-KRT) stage, requiring their first hemodialysis (HD) AV access creatio
You may qualify if:
- \- adult patients between the ages of 18 and 80 who were referred for primary hemodialysis (HD) AV access creation. We included those in the pre-kidney replacement therapy (pre-KRT) stage and those who in the early end-stage kidney disease (ESKD) urgently started HD without sufficient time to plan for AV access
You may not qualify if:
- \- patients who underwent a secondary AV access surgery, like a transposed radiobasilic AVF or a revision of AVG.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chih-Yang Chan, phd
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
April 9, 2024
First Posted
April 15, 2024
Study Start
October 13, 2023
Primary Completion
May 7, 2024
Study Completion
July 31, 2025
Last Updated
June 19, 2025
Record last verified: 2025-05